Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
04/28/1991 | CA2071530A1 Diagnosis of glomerulonephritis |
04/28/1991 | CA2071502A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
04/28/1991 | CA2066644A1 Method for treating hiv and other retroviruses and compounds useful therefor |
04/28/1991 | CA2028517A1 Enhancement of porcine somatotropin activity |
04/26/1991 | CA2027852A1 Food additives |
04/25/1991 | WO1991006647A1 Gastrin releasing peptide receptor |
04/25/1991 | WO1991006646A1 Solubilization and purification of the gastrin releasing peptide receptor |
04/25/1991 | CA2069965A1 Solubilization and purification of the gastrin releasing peptide receptor |
04/25/1991 | CA2067821A1 Infective drug delivery system using recombinant retroviral vectors |
04/25/1991 | CA2067766A1 Gastrin releasing peptide receptor |
04/24/1991 | WO1991005799A1 Polypeptide inhibitors of gamma interferon |
04/24/1991 | EP0424351A2 Modified heparin cofactor II |
04/24/1991 | EP0424318A1 Process for preparing protease inhibitors |
04/24/1991 | EP0424117A1 Yeast promoter |
04/24/1991 | EP0424107A1 A novel tumor-associated antigen |
04/24/1991 | EP0424051A1 Glycopeptide antibiotics |
04/24/1991 | EP0423980A1 Stem cell factor |
04/24/1991 | EP0423890A2 Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant DNA technology |
04/24/1991 | EP0423869A1 Infectious bronchitis virus vaccine |
04/24/1991 | EP0423845A1 A synthetic gene encoding gamma-interferon |
04/24/1991 | EP0423649A1 Peptides and use thereof |
04/24/1991 | EP0423641A2 Expression vector, transformed microorganism, fusion protein and method for the production of platelet factor 4 or TGFalpha |
04/24/1991 | EP0423502A1 Flower-inducing substances and a method for production thereof |
04/24/1991 | EP0423333A1 Anti-endoserine antibody |
04/24/1991 | EP0423326A1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient |
04/24/1991 | EP0423322A1 Grf analogs viia. |
04/24/1991 | EP0423317A1 Invasive microorganisms |
04/24/1991 | EP0423315A1 Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine |
04/24/1991 | EP0423302A1 Application of novel dna fragments as a coding sequence for a signal peptide for the secretion of mature proteins by recombinant yeast, expression cassettes, transformed yeasts and corresponding process for the preparation of proteins. |
04/24/1991 | EP0423264A1 Recombinant cold shock protein, production and use in agriculture |
04/24/1991 | EP0423262A1 Protein fraction from the photosynthesis apparatus of plants for use as an active substance in the selective destruction of cancer cells and the post-treatment of scars, keloids and inflammatory processes and pharmaceutical products containing it. |
04/24/1991 | EP0423252A1 Tumour necrosis factor muteins |
04/24/1991 | EP0423239A1 Post-transfusion, non-a, non-b hepatitis virus and antigens |
04/24/1991 | EP0423238A1 Synthetic vaccine against p. falciparum malaria |
04/24/1991 | EP0423236A1 Peptides with extraordinary opioid receptor selectivity |
04/24/1991 | EP0423224A1 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor |
04/24/1991 | EP0423207A1 A migration stimulating factor |
04/24/1991 | EP0423193A1 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human |
04/24/1991 | CN1050899A Novel entities for cancer therapy |
04/24/1991 | CA2070416A1 Polypeptide inhibitors of gamma interferon |
04/24/1991 | CA2028172A1 Synthetic envelope peptides of htlv-i |
04/23/1991 | US5010182 DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
04/23/1991 | US5010176 Malonate linker |
04/23/1991 | US5010174 Novel calcitonin derivative and salt thereof |
04/23/1991 | US5010097 Collagenase inhibitors, antiarthritic agents |
04/23/1991 | US5010057 Renin-inhibiting peptides having an aminomethyl side chain |
04/23/1991 | US5010015 Plasmid capable of multiplying in bacillus, regulation and secretion signal sequences of the amylase gene and the dna sequence encoding for the protein or polypeptide |
04/23/1991 | US5010011 Bovine placental lactogen gene |
04/23/1991 | US5010010 DNA sequence encoding Saccharomyces mating factor alpha 1 linked to human parathyroid hormone stably transforms yeast cell to express and secrete the hormone |
04/23/1991 | US5010001 Growing excherichia with expression vector containing gene encoding for endotoxin; isolation of bacillus delta-endotoxin |
04/23/1991 | US5010000 Method for the preparation of a selected protein or a part thereof in Bacillus strain bacteria |
04/23/1991 | CA1283499C Peptides |
04/23/1991 | CA1283374C Recombinant dna expression vectors and method for gene expression |
04/23/1991 | CA1283373C Use of the gal 1 yeast promoter |
04/23/1991 | CA1283358C Insulin preparation |
04/21/1991 | WO1991005865A1 Dna, constructs, cells and plants derived therefrom |
04/21/1991 | WO1991005805A1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR |
04/21/1991 | CA2028082A1 Modified heparin cofactor ii |
04/21/1991 | CA2028045A1 Infectious bronchitis virus vaccine |
04/21/1991 | CA2028024A1 Tumor-associated antigen |
04/20/1991 | WO1991006006A1 Carrier for binding antiphospholipid antibody, immunoassay using the same, and kit therefor |
04/20/1991 | CA2044142A1 Carrier for binding of anti-phospholipid antibodies, an immunoassay method using the same and a kit therefor |
04/19/1991 | WO1991005793A1 Production and use of human nm23 protein and antibodies therefor |
04/19/1991 | WO1991005565A1 BIOSYNTHETIC CONSTRUCTS OF TGF-$g(b) |
04/19/1991 | CA2070393A1 Biosynthetic constructs of tgf-beta |
04/18/1991 | WO1991005264A1 Detection and quantification of neu related proteins in the biological fluids of humans |
04/18/1991 | WO1991005057A1 Cd4 production in pichia pastoris |
04/18/1991 | WO1991005053A1 Cloning and expression of microbial phytase |
04/18/1991 | WO1991005052A1 Method for obtaining a polypeptide with human-interleukin-2 activity, secreted by yeast cells, saccharomyces cerevisiae |
04/18/1991 | WO1991005051A1 Method of obtaining human-interleukin-2 polypeptide in yeast cells |
04/18/1991 | WO1991005050A1 Synthesis of mature human parathyroid hormone |
04/18/1991 | WO1991005048A1 Mutants of the human plasminogen activator inhibitor 1 (pai-1), their preparation and use |
04/18/1991 | WO1991005047A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
04/18/1991 | WO1991005046A1 Granulocyte-colony stimulating factor receptors |
04/18/1991 | WO1991005045A1 PORCINE LACTOFERRIN AMINO ACID AND cDNA SEQUENCE |
04/18/1991 | WO1991005044A1 A culture of saccharomyces cervisiae containing the gene responsible for huntington's disease and uses thereof |
04/18/1991 | WO1991005041A1 Erythroid-specific gene expression system |
04/18/1991 | WO1991005040A1 Cloned genes for human dopamine d2 receptors and cell lines expressing same |
04/18/1991 | WO1991004986A1 Oligopeptides/expression products of the aujeszky's disease virus, and recombinant polynucleotides coding therefor |
04/18/1991 | WO1991004967A1 Compounds useful for measuring low levels of sulfonylureas by immunoassay |
04/18/1991 | WO1991004748A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
04/18/1991 | WO1991004747A1 Protection vaccine against swine hemophilosis |
04/18/1991 | WO1991004743A1 Stabilized aqueous formulations of small peptides |
04/18/1991 | WO1991004728A2 Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome |
04/18/1991 | WO1991004316A3 Ciliary neurotrophic factor |
04/18/1991 | WO1991002805A3 Recombinant retroviruses delivering vector constructs to target cells |
04/18/1991 | WO1990015076A3 MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE |
04/18/1991 | WO1990015066A3 Nucleotidic sequences resulting from the retrovirus gemone of the hiv-1, hiv-2, and siv type, and their applications, in particular for the amplification of the genomes of said retroviruses and for the in vitro diagnosis of infections caused by these viruses |
04/18/1991 | DE3934366A1 Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum Vaccine to protect against hiv virus infections, methods for their production and their use as diagnostic and immunotherapeutic |
04/18/1991 | DE3933850A1 Zytolyse-inhibitor (zli), eine diese blutplasmaprotein kodierende dna-sequenz, sowie ein plasmid, ein wirtsorganismus und ein verfahren zur gewinnung dieses proteins Cytolysis inhibitor (ZLI), these a blood plasma protein encoding DNA sequence, and a plasmid, a host organism and a method for obtaining this protein |
04/18/1991 | CA2027725A1 Use of a polypeptide with human interleukin-2 activity for preparation of pharmaceutical compositions used in leukemia treatment |
04/17/1991 | WO1991005861A1 Non-specific dna amplification |
04/17/1991 | WO1991005860A1 Non-infectious hiv-1 particles and uses therefor |
04/17/1991 | EP0422938A1 Fibrinogen receptor antagonists |
04/17/1991 | EP0422937A1 Fibrinogen receptor antagonists |
04/17/1991 | EP0422769A1 Albumin purification |
04/17/1991 | EP0422762A2 Method for assessing the sensitivity of HIV-1 to zidovudine and oligonucleotides therefore |
04/17/1991 | EP0422697A1 A consensus leukocyte interferon and a gene encoding it |
04/17/1991 | EP0422339A1 Tumor necrosis factor (TNF) inhibitor and method for obtaining the same |
04/17/1991 | EP0422217A1 Human recombinant placental ribonuclease inhibitor and method of production |